The application of a plasmid DNA encoding IFN-α1 postinfection enhances cumulative survival of herpes simplex virus type 2 vaginally infected mice1

Journal of Immunology

Volumn 166, Issue 3, 2001, Pages 1803-1812

  Harle P ^a   Noisakran, S ^a   Carr, D J J ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA1 INTERFERON; PLASMID DNA; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; FEMALE GENITAL TRACT INFECTION; GENITAL HERPES; HERPES SIMPLEX VIRUS 2; IMMUNE RESPONSE; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0035253710     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.3.1803     Document Type: Article

References (63)

1. Herpes simplex viruses
2. Prevalence and correlates of herpes simplex infections: The population-bases AIDS in multiethnic neighborhoods study
3. Herpes simplex virus type 2 in the United States, 1974 to 1994
4. A prospective study of new infections with herpes simplex virus type 1 and 2
5. Recurrences after oral and genital herpes simplex virus infections: Influence of site of infection and viral type
6. Prior herpes simplex virus type 2 infection as a risk factor for HIV infection
7. The association between genital ulcer disease and acquisition of HIV infection in homosexual men
8. Herpes simplex virus type 2 and other genital ulcerative infections as a risk factor for HIV-1 acquisition
9. Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals
10. Prevalence and incidence of herpes simplex virus type 2 infection among male Zimbabwean factory workers
11. Mucosal immune system of the genital tract
12. Immunity in the female genital tract after intravaginal vaccination of mice with an attenuated strain of herpes simplex virus type 2
13. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2
14. Migration of lymphoid cells from vaginal epithelium to iliac nodes in relation to vaginal infection by herpes simplex virus type 2
15. Protective immunity against HSV-2 in the mouse vagina
16. Neutrophils aid in protection of the vaginal mucosae of immune mice against challenge with herpes simplex virus type 2
17. T lymphocytes in genital lymph nodes protect mice from intravaginal infection with herpes simplex virus type 2
18. Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2
19. + cytotoxic T-lymphocyte precursors specific for herpes simplex virus in persons with genital herpes
20. Mucosal immunity to herpes simplex virus type 2 infection in the mouse vagina is impaired by in vivo depletion of T lymphocytes
21. + cytotoxic T lymphocyte responses
22. Interferon-γ enhances resolution of herpes simplex virus type 2 infection of the murine genital tract
23. Generation of humoral immune responses against herpes simplex virus type 2 in the murine female genital tract
24. Immunity to vaginal HSV-2 infection in immunoglobulin A knockout mice
25. Vaccination with recombinant herpes simplex virus glycoproteins: Protection against initial and recurrent genital herpes
26. Influence of mucosal and parenteral immunization with a replication-defective mutant of HSV-2 on immune responses and protection from genital challenge
27. DNA immunization against experimental genital herpes simplex virus infection
28. + T cell-mediated protective immunity against herpes simplex virus-2 challenge
29. In vivo modulation of vaccine-induced immune responses toward a Th1 phenotype increases the potency and vaccine effectiveness in a herpes simplex virus type 2 mouse model
30. HSV growth, preparation, and assay
31. Ectopic expression of DNA encoding IFN-α1 in the cornea protects mice from herpes simplex virus type 1-induced encephalitis
32. High efficiency transformation of mammalian cells by plasmid DNA
33. IFN induction and associated changes in splenic leukocyte distribution
34. Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type 1
35. Detection of herpes simplex virus using the polymerase chain reaction followed by endonuclease cleavage
36. Frequent detection of genital herpes simplex virus DNA by polymerase chain reaction among pregnant women
37. Central α-adrenergic involvement in morphine-mediated suppression of splenic natural killer activity
38. Glycoproteins specified by herpes simplex viruses
39. IL-4 and IFN (α and γ) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones
40. + T cells
41. Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development
42. Type I interferons keep activated T cells alive
43. Early expression of IFN-αβ and iNOS in the brains of Venezuelan equine encephalitis virus-infected mice
44. Inhibition of viral replication by interferon-γ-induced nitric oxide synthase
45. Mice lacking inducible nitric-oxide synthase are more susceptible to herpes simplex virus infection despite enhanced Th1 cell responses
46. Enhanced NK activity in mice injected with interferon and interferon inducers
47. In vivo significance of NK cell on resistance to virus (HSV-1) infections in mice
48. DNA immunization against experimental genital herpes simplex virus infection
49. Nucleic acid vaccine encoding gD2 protects mice from herpes simplex virus type 2 disease
50. Baculovirus-expressed glycoprotein E (gE) of herpes simplex virus type 1 (HSV-1) protects mice against lethal intraperitoneal and lethal ocular HSV-1 challenge
51. IFN-αl plasmid construct affords protection against HSV-1 infection in transfected L929 fibroblasts
52. Cell-mediated DNA transport between distant inflammatory sites following intradermal DNA immunization in the presence of adjuvant
53. Distribution fate and mechanism of immune modulation following mucosal delivery of plasmid DNA encoding IL-10
54. Effect of interferon treatment on interferon production
55. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: A role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA
56. Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages/antigen-presenting cells
57. Proinflammatory functions of IL-2 in herpes simplex virus corneal infection
58. IFN-γ is produced by polymorphonuclear neutrophils in human uterine endometrium and by cultured peripheral blood polymorphonuclear neutrophils
59. Mucosal and systemic antiviral antibodies in mice inoculated intravaginally with herpes simplex virus type 2
60. DNA immunization confers protective immunity on mice challenged intravaginally with herpes simplex virus type 2
61. Induction of mucosal immunity against herpes simplex virus plasmid DNA immunization
62. Immunization of the female genital tract with a DNA-based vaccine